QH103 Cell Injection

BIOLOGICAL3 trials

Sponsors

Anhui Provincial Hospital, The Second Affiliated Hospital of Fujian Medical University, Fujian Medical University

Conditions

B-cell Acute Lymphoblastic LeukemiaRecurrent/Refractory B-cell LymphomaRelapsed/Refractory CD19-positive B-ALL

Phase 1

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

RecruitingNCT06056752

Anhui Provincial HospitalB-cell Acute Lymphoblastic Leukemia

Start: 2023-09-27End: 2026-07-03Target: 10Updated: 2023-10-24

Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma

Not yet recruitingNCT07367685

The Second Affiliated Hospital of Fujian Medical UniversityRecurrent/Refractory B-cell Lymphoma

Start: 2026-05-01End: 2028-12-31Target: 6Updated: 2026-01-26

Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia

Not yet recruitingNCT07491263

Fujian Medical UniversityRelapsed/Refractory CD19-positive B-ALL

Start: 2026-05-01End: 2028-12-31Target: 6Updated: 2026-03-24